These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 14752841

  • 1. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S.
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [Abstract] [Full Text] [Related]

  • 2. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
    Tamada S, Shibahara H, Higashi M, Goto M, Batra SK, Imai K, Yonezawa S.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4257-64. PubMed ID: 16857800
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN, Pang ST, Wu RC, Chen TW, Jan YY, Chen MF.
    Oncol Rep; 2009 Jan 15; 21(1):49-56. PubMed ID: 19082442
    [Abstract] [Full Text] [Related]

  • 4. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M, Yonezawa S, Ho JJ, Tanaka S, Irimura T, Kim YS, Sato E.
    Hepatology; 1999 Dec 15; 30(6):1347-55. PubMed ID: 10573510
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb 15; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 6. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
    Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, Wakimoto J, Batra SK, Imai K, Yonezawa S.
    Lung Cancer; 2007 Feb 15; 55(2):195-203. PubMed ID: 17126950
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Iguchi T, Taketomi A, Maehara Y, Tsuneyoshi M.
    Hum Pathol; 2007 Dec 15; 38(12):1819-25. PubMed ID: 17854859
    [Abstract] [Full Text] [Related]

  • 8. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma.
    Park BK, Paik YH, Park JY, Park KH, Bang S, Park SW, Chung JB, Park YN, Song SY.
    Am J Clin Oncol; 2006 Apr 15; 29(2):138-42. PubMed ID: 16601431
    [Abstract] [Full Text] [Related]

  • 9. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
    Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.
    Histopathology; 2006 Jul 15; 49(1):35-44. PubMed ID: 16842244
    [Abstract] [Full Text] [Related]

  • 10. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H.
    J Surg Oncol; 2007 Aug 01; 96(2):160-5. PubMed ID: 17443744
    [Abstract] [Full Text] [Related]

  • 11. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Miyazaki M.
    Br J Surg; 2002 Dec 01; 89(12):1525-31. PubMed ID: 12445060
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.
    Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T, Ojima H.
    Surgery; 2009 Apr 01; 145(4):411-6. PubMed ID: 19303990
    [Abstract] [Full Text] [Related]

  • 13. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma.
    Weed DT, Gomez-Fernandez C, Pacheco J, Ruiz J, Hamilton-Nelson K, Arnold DJ, Civantos FJ, Zhang J, Yasin M, Goodwin WJ, Carraway KL.
    Head Neck; 2004 Apr 01; 26(4):353-64. PubMed ID: 15054739
    [Abstract] [Full Text] [Related]

  • 14. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T, Asahara T, Katayama K, Nakahara H, Fukuda T, Yano M, Hino H, Nakahara M, Dohi K, Shimamoto F.
    Hepatogastroenterology; 2001 Apr 01; 48(40):1129-33. PubMed ID: 11490816
    [Abstract] [Full Text] [Related]

  • 15. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Kinoshita H.
    Hepatogastroenterology; 2002 Apr 01; 49(44):326-9. PubMed ID: 11995443
    [Abstract] [Full Text] [Related]

  • 16. MUC4 and ErbB2 expression in squamous cell carcinoma of the upper aerodigestive tract: correlation with clinical outcomes.
    Weed DT, Gomez-Fernandez C, Yasin M, Hamilton-Nelson K, Rodriguez M, Zhang J, Carraway KL.
    Laryngoscope; 2004 Aug 01; 114(8 Pt 2 Suppl 101):1-32. PubMed ID: 15284539
    [Abstract] [Full Text] [Related]

  • 17. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.
    Hum Pathol; 2009 Dec 01; 40(12):1706-14. PubMed ID: 19683330
    [Abstract] [Full Text] [Related]

  • 18. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC, Hsu C, Kao HL, Jeng YM.
    Cancer Lett; 2006 Apr 08; 235(1):34-9. PubMed ID: 16125303
    [Abstract] [Full Text] [Related]

  • 19. What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
    Paik KY, Jung JC, Heo JS, Choi SH, Choi DW, Kim YI.
    J Gastroenterol Hepatol; 2008 May 08; 23(5):766-70. PubMed ID: 17868336
    [Abstract] [Full Text] [Related]

  • 20. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M.
    Mod Pathol; 2002 Nov 08; 15(11):1181-90. PubMed ID: 12429797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.